Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Celance 1mg tablets
0409010P0BBACAC
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Celance 250microgram tablets
0409010P0BBABAB
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Celance 50microgram tablets
0409010P0BBAAAA
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Celance tablets 14 day starter pack
0409010P0BBADAE
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Celance tablets 30 day starter pack
0409010P0BBAEAE
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Pergolide 1mg tablets
0409010P0AAACAC
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
|
Pergolide 250microgram tab and Pergolide 50microgram tab
0409010P0AAAEAE
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
|
Pergolide 250microgram tablets
0409010P0AAABAB
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
|
Pergolide 50microgram tablets
0409010P0AAAAAA
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.